Summary
Updated Aug 31, 2026
Paul F. Lizzul is Chief Medical Officer of First Tracks Biotherapeutics, Inc. (TRAX). 7 SEC Form 4 filings on record, most recently on 18 August 2026. Most recent open-market trade: sold $163K of ANAB on 10 January 2026. Lifetime open-market sales: $264K.
Recent Transactions
4Every recent SEC Form 4 transaction Paul F. Lizzul has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Paul F. Lizzul go back to 2026: 7 primary Form 4 filings, an average of 7.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul F. Lizzul files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $65.00M of TRAX open-market activity in the last 12 months
- Daniel Faga - $2.14M of ANAB open-market activity in the last 12 months
- Eric J. Loumeau - $1.32M of ANAB open-market activity in the last 12 months
- John P. Schmid - $1.16M of ANAB open-market activity in the last 12 months
- Magda Marquet - $531K of ANAB open-market activity in the last 12 months
- Dennis Mulroy - $199K of ANAB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul F. Lizzul?
Paul F. Lizzul is a corporate insider, tracked as Chief Medical Officer of First Tracks Biotherapeutics, Inc. (TRAX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul F. Lizzul submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Paul F. Lizzul been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($264K) across all tracked filings.
Where can I see all of Paul F. Lizzul's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul F. Lizzul and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial